Dr Lalchand. Lab

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE871Z01013
  • NSEID:
  • BSEID: 541299
INR
8.52
-0.15 (-1.73%)
BSENSE

Jun 15

BSE+NSE Vol: 144000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002986,
    "name": "Dr Lalchand. Lab",
    "stock_name": "Dr Lalchand. Lab",
    "full_name": "Dr Lalchandani Labs Ltd",
    "name_url": "stocks-analysis/dr-lalchand-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "8.52",
    "chg": -0.15,
    "chgp": "-1.73%",
    "dir": -1,
    "prev_price": "8.67",
    "mcapval": "8.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541299,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE871Z01013",
    "curr_date": "Jun 15",
    "curr_time": "",
    "bse_nse_vol": 144000,
    "exc_status": "Active",
    "traded_date": "Jun 15, 2026",
    "traded_date_str": "2026 06 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/dr-lalchand-lab-1002986-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 54,
    "sid": "1002986",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/dr-lalchandani-labs-1002986"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Approval Of Audited Financial Statement For Half Year And Year Ended March 31 2026",
      "datetime": "03-Jun-2026",
      "details": "Audited Financial Results for the quarter and year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Approval Of Audited Financial Results For The Half Year And Year Ended March 31 2026",
      "datetime": "03-Jun-2026",
      "details": "Audited Financial Results for the half year and year ended March 31 2206",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Meeting Updates",
      "datetime": "30-May-2026",
      "details": "Intimation of Postponement and Rescheduling of Board Meeting scheduled to be held on Today May 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lalchandani Labs Ltd has announced <strong>1:1</strong> rights issue, ex-date: 27 Jan 26",
          "dt": "2026-01-27",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Board Meeting Outcome for Approval Of Audited Financial Statement For Half Year And Year Ended March 31 2026

03-Jun-2026 | Source : BSE

Audited Financial Results for the quarter and year ended March 31 2026

Approval Of Audited Financial Results For The Half Year And Year Ended March 31 2026

03-Jun-2026 | Source : BSE

Audited Financial Results for the half year and year ended March 31 2206

Announcement under Regulation 30 (LODR)-Meeting Updates

30-May-2026 | Source : BSE

Intimation of Postponement and Rescheduling of Board Meeting scheduled to be held on Today May 30 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Dr Lalchandani Labs Ltd has announced 1:1 rights issue, ex-date: 27 Jan 26